Government support for proteomics, increased research & development, rising need for customized medicine, and technical improvements are some of the reasons likely to drive expansion of the global proteomics market. Since it is difficult for corporations to pinpoint all of the required information to cover all of the tasks involved in proteomics, collaborations are becoming increasingly crucial in this discipline. Rising demand for customized pharmaceuticals, as well as increased research and development activities are further likely to propel the global proteomics market forward. The growth of this market, however, is impeded by high cost of the instruments and strict regulatory requirements.
One of the most exciting discoveries in the science of human proteins and genes has been the detection of potential new medications for the treatment of illness. This is built on the understanding of genome and proteome for finding proteins connected to a disorder that may then be used by computer programs as targets for new drugs. To evaluate the impact of these drug candidates on the cellular systems and also model organisms, preclinical levels in the process of drug development require a variety of genetic as well as biochemical tests. Nearly every single major pharmaceutical business today has a proteome-focused academic or biotech partner, or it has established its own unit of proteomics.
Proteomics can be defined as the study of proteomes. Proteomes are a set of proteins which are produced in a system, organism, or any biological context. Proteomes vary from cell to cell and changes over a period of time. Proteomics is used in various applications, such as, to investigate protein expression, in transcriptional and post transcriptional studies, metabolic pathways, to study protein interaction in diseases viz. cancer, to study localization of sub cellular proteins, etc. Proteomics can be studied using various technologies, such as, mass spectrometry, gel-based techniques, and others.
The global proteomics market is expected to grow at a significant CAGR during the forecast period. Increasing research & development activities in the healthcare industries, rising demand for personalized medicines, and increasing activities of drug discovery are some of the important factors expected to contribute to the growth of the global proteomics market during the forecast period. Rise in use of proteomics to study cancer genes and protein interaction in cancer genes is projected to drive the growth of the global proteomics market due to high prevalence of cancer across the world. Factors such as application of proteomics in the diagnosis of infectious diseases, technological advancement, increase in health care expenditure, rise in awareness, etc. are the other factors likely to boost the growth of the global proteomics market during the forecast period. However, inadequate funding and lack of awareness regarding the application of proteomics in developing countries are anticipated to restrain the growth of global proteomics market during the forecast period.
The global proteomics market can be segmented on the basis of product, services, application, and region. Based on product, the global proteomics market can be divided into instrumentation and reagents. The instrumentation segment can be further classified into spectrometry, chromatography, X-ray, immunoassay, electrophoresis, and others. In terms of services, the global market can be segmented into analytical laboratory services, sequencing, protein identification, bioinformatics, and others. The anatomical laboratory services segment is expected to hold a significant share of the market during the forecast period due to effectiveness of services provided by anatomical laboratories in diagnosis and drug discovery. On the basis of application, the global proteomics market can be categorized into clinical diagnosis, drug discovery, and others. The clinical diagnosis segment is expected to hold a significant share of the market during the forecast period due to rise in prevalence of cancer, increase in incidence of infectious diseases, etc. across the globe.
The global proteomics market is expected to grow at significant rate in all geographical regions. Based on region, the global market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is expected to dominate the global proteomics market throughout the forecast period. Factors influencing the growth of market in North America include rise in funding from government, increase in research activities, high awareness regarding applications of proteomics, improved health care infrastructure, high health care expenditure, and rise in prevalence of cancer in the region. Europe is projected to be the second leading market for proteomics during the forecast period due to increase in cancer research activities, high funding from the government, and presence of key market players in the region. Driver The proteomics market in Asia Pacific is estimated to expand at a significantly high CAGR during the forecast period. Growth drivers of the proteomics market in the region include high prevalence of cancer, rising health care expenditure, presence of a large number of drug manufactures in countries such as India and Japan leading to increase in drug discovery, and high prevalence of infectious diseases in the region.
In order to maintain a significant position in the global proteomics market, key players are adopting strategies, such as, mergers & acquisitions, geographical expansion, research & development, etc. Leading players operating in the global proteomics market include GE Healthcare, Bio-Rad Laboratories, Inc., Danaher Corporation, and PerkinElmer, Inc.